| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Pridgen William serves as a Director at DWTX. Across recent SEC filings that breaks down to 11 buys and 0 sells. Those positions are worth an estimated $112K at current prices.
Historically, Pridgen William's trades have earned a below-average insider score of 28/100 across 9 rated trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -82.3%.
The biggest single holding is DWTX (~$112K) as Director. Net of sales, the recent Form 4 record there shows accumulation of 52,987 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 17, 2020 | DWTX Dogwood Therapeutics, Inc. | Director | Buy | 1,500 | $11.98 | $17,970.00 | +0.2% |